Sulfoquinovosylacylpropanediol is a novel potent radiosensitizer in prostate cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1442-2042|22|6|590-595

ISSN： 0919-8172

Source： INTERNATIONAL JOURNAL OF UROLOGY, Vol.22, Iss.6, 2015-06, pp. : 590-595

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial Comment from Dr Miyata and Dr Sakai to Sulfoquinovosylacylpropanediol is a novel potent radiosensitizer in prostate cancer

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 6, 2015-06 ,pp. : 597-597

John Wiley & Sons Inc

Access to resources Recommend Favorite

Editorial Comment from Dr Wu to Sulfoquinovosylacylpropanediol is a novel potent radiosensitizer in prostate cancer

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 6, 2015-06 ,pp. : 596-596

John Wiley & Sons Inc

Access to resources Recommend Favorite

Novel approaches for the treatment of prostate cancer

By Arlen Philip M  

Therapy, Vol. 5, Iss. 1, 2008-01 ,pp. : 1-2

Future Medicine

Access to resources Recommend Favorite

EN2: a novel prostate cancer biomarker

By McGrath Sophie E   Michael Agnieszka   Morgan Richard   Pandha Hardev  

Biomarkers in Medicine, Vol. 7, Iss. 6, 2013-12 ,pp. : 893-901

Future Medicine

Access to resources Recommend Favorite

A novel randomised controlled trial design in prostate cancer

By  

BJU INTERNATIONAL, Vol. 116, Iss. 1, 2015-07 ,pp. : 6-8

John Wiley & Sons Inc

Access to resources Recommend Favorite